These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16026494)

  • 21. Putative neuroleptic malignant syndrome associated with sertraline withdrawal.
    Konstantakopoulos G; Kouzoupis AV; Papageorgiou SG; Oulis P
    J Clin Psychopharmacol; 2009 Jun; 29(3):300-1. PubMed ID: 19440088
    [No Abstract]   [Full Text] [Related]  

  • 22. Rhabdomyolysis With Risperidone and Escitalopram Coadministration: A Case Report.
    Mermelstein AC; Mermelstein J
    J Clin Psychopharmacol; 2016 Feb; 36(1):97-8. PubMed ID: 26658087
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
    Dombrovski AY; Mulsant BH; Ferrell RE; Lotrich FE; Rosen JI; Wallace M; Houck PR; Mazumdar S; Pollock BG
    Int Clin Psychopharmacol; 2010 Jan; 25(1):37-45. PubMed ID: 19996755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malignant neuroleptic syndrome and hyponatremia associated with risperidone poisoning].
    Epelde Gonzalo F
    An Med Interna; 2002 Jan; 19(1):50. PubMed ID: 11989083
    [No Abstract]   [Full Text] [Related]  

  • 25. A Case of neuroleptic malignant syndrome accompanied to an atypical antipsychotic agent: risperidone.
    Pasa S; Sayhan MB; Boyraz T; Urakci Z; Altintas A
    Neurotoxicology; 2008 Jul; 29(4):750-1. PubMed ID: 18539333
    [No Abstract]   [Full Text] [Related]  

  • 26. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F; Geerlings CJ; Rietveld AP
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract]   [Full Text] [Related]  

  • 27. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
    Newman M; Adityanjee ; Jampala C
    Am J Psychiatry; 1997 Oct; 154(10):1475. PubMed ID: 9326841
    [No Abstract]   [Full Text] [Related]  

  • 28. A case of neuroleptic malignant syndrome with clozapine and risperidone.
    Beauchemin MA; Millaud F; Nguyen KA
    Can J Psychiatry; 2002 Nov; 47(9):886. PubMed ID: 12500761
    [No Abstract]   [Full Text] [Related]  

  • 29. Delayed risperidone-induced neuroleptic malignant syndrome.
    Kern JL; Cernek PK
    Ann Pharmacother; 1996 Mar; 30(3):300. PubMed ID: 8833573
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T; Westendorp RG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuroleptic malignant syndrome in users of risperidone].
    Vorel SK; Bos F; Vorel-Havelkova E; Brombacher PJ
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):159-60; author reply 160. PubMed ID: 15693596
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neuroleptic malignant syndrome in users of risperidone].
    Kroon JG
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome in the burns patient?
    Cawrse N; Wilson S; Williams M; Burge T
    Burns; 2006 Aug; 32(5):647-9. PubMed ID: 16777336
    [No Abstract]   [Full Text] [Related]  

  • 34. Comment: neuroleptic malignant syndrome associated with risperidone and fluvoxamine.
    Isbister GK; Dawson AH; Whyte IM
    Ann Pharmacother; 2002; 36(7-8):1293; author reply 1294. PubMed ID: 12086569
    [No Abstract]   [Full Text] [Related]  

  • 35. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
    Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
    An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidone and neuroleptic malignant syndrome. Recognizing a potentially fatal condition.
    Shuster J
    Nursing; 1997 Mar; 27(3):68. PubMed ID: 9171635
    [No Abstract]   [Full Text] [Related]  

  • 37. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    Teng PR; Lane HY
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome with risperidone.
    Levin GM; Lazowick AL; Powell HS
    J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel clinical observation in neuroleptic malignant-like syndrome: first demonstration of early progression of hydrocephalus.
    Kazdal H; Kanat A; Sen A; Kirbas S; Ardic G; Tufekci A; Ersoz T
    J Clin Psychopharmacol; 2015 Apr; 35(2):211-2. PubMed ID: 25679124
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroleptic malignant syndrome in a patient treated with olanzapine].
    Horni G; Meirik K; Lund MB
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.